Home

Latest News

  • MOA between CUT and AiBST

    Breaking News

    On Friday the 18th of May 2018, Chinhoyi University of Technology
    Read more...  
  • Hugo Award

    Trophy   Prof Collen Masimirembwa was awarded (HUGO)

    Read More

     
  • Upcoming Events

    No Events....

Vision : Provision of Life Transforming Healthcare Solutions for Africa

Molecular Diagnostics

techniques used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells. Read more...

Genomic and Pharmaceutical Medicine

an emerging medical discipline that involves using genomic information about an individual as part of their clinical care Read more...

Forensic Science

application of science to criminal and civil laws,during criminal investigation, as governed by the legal standards of admissible evidence and criminal procedure. Read more...

Post Graduate Training

designed to prepare researchers, laboratory scientists and postgraduate students with the practical knowledge for undertaking molecular. Read more...
  • Register

Welcome To Aibst

The African Institute of Biomedical Science and Technology, AiBST, is a research and education institute with a mission to discover, develop and deploy innovative healthcare solutions for Africa. Combining postgraduate education and biomedical R&D is enabling AiBST to operate in an environment which still requires capacity and capability building with respect to skilled manpower and research infrastructure,whilst conducting translational research to deliver on medical products and services that address Africa’s healthcare challenges.

AiBST was founded in 2002 by Professor Collen Masimirembwa. Its initial activities were the organisation of courses on the science and technology of drug discovery and development. The first course was in Cape Town (South Africa) in 2002 andfocused on ADMET for drug discovery. The second one was in Nairobi (Kenya) in 2003 focusing on Pharmacogenetics of Drug Metabolism.

The courses generated tremendous interest among African scientists resulting in them forming the African Society for Drug Metabolism and Development (ASDMD) at the meeting in Cape Town and the African Pharmacogenomics Consortium at the meeting in Nairobi. AiBST demonstrated a viable interface African researchers and internationalacademics and industrialists could work together to establish capacity for biopharmaceutical R&D in Africa. With support from pharmaceutical companies such as AstraZeneca, Novartis, and Merck, funding organizations such as WHO-TDR,CDC(Atlanta), ISP, EDCTP, NIH, SANBIO, BfArM and TWAS, AiBST establishedstate-of- the-art biomedical research laboratories and a Phase I Clinical Trial Unit in Zimbabwe.

Read More

Guests Online

We have 3 guests and no members online